FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

24328411000001107: Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110261000001115 Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110271000001113 Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Benz) true Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Is a Product containing precisely nitrazepam 500 microgram/1 milliliter conventional release oral suspension true Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Nitrazepam false Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Has specific active ingredient Nitrazepam true Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has AMP True Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 70 ml Has AMP True Nitrazepam 2.5mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start